Immunological evaluation of personalized peptide vaccination in refractory small cell lung cancer

Since the prognosis of small cell lung cancer (SCLC) remains poor, development of new therapeutic approaches, including immunotherapies, would be desirable. In the current study, to evaluate immunological responses in refractory SCLC patients, we conducted a small scale phase II clinical trial of pe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Terazaki, Yasuhiro, Yoshiyama, Koichi, Matsueda, Satoko, Watanabe, Noriko, Kawahara, Akihiko, Naito, Yoshiki, Suekane, Shigetaka, Komatsu, Nobukazu, Ioji, Tetsuya, Yamada, Akira, Mine, Takashi, Terasaki, Mizuhiko, Itoh, Kyogo, Takamori, Shinzo, Sasada, Tetsuro
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2012
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7659229/
https://ncbi.nlm.nih.gov/pubmed/22321067
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.2012.02202.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados